Sign In
to Vote &
Create Storyboards.
 
The Medical Imaging & Technology Alliance (MITA) has issued the following statement in response to the Centers for Medicare & Medicaid Services' (CMS) final decision to cover beta amyloid positron emission tomography (PET) imaging under coverage with evidence development (CED) for patients enrolled in an approved clinical study. "MITA appreciates CMS's attention to the serious concerns raised by the Alzheimer's disease community about the initial draft coverage decision and made progress in its ...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard